Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether offering an evidence-based package of employment supports integrated with mental health services has a positive impact on employment and clinical recovery, and delays or diminishes the need for disability benefits.


Clinical Trial Description

SSA contracted with Westat to implement and evaluate the Supported Employment Demonstration (SED). The SED provides integrated mental health and vocational services to people with mental illness who were recently denied Social Security disability benefits. The evaluation will determine the impact of the SED on employment, clinical recovery, and receipt of disability payments. The evaluation is using a randomized controlled trial design to compare the outcomes of two treatment groups and a control group. In the full-service arm (n = 1,000), participants receive services from an Individual Placement and Support employment specialist, a care manager, and a nurse care coordinator (NCC) who provides medication management support, as well as modest funding for out-of-pocket prescriptions, essential work-related expenses, and other services in the participant's treatment plan. The basic-service arm (n=1,000), which is expected to cost about 50 percent less than the full-service arm, provides all services and funds except the NCC. Participants in the usual services (control) group (n = 1,000) seek services as they normally would but receive a comprehensive guide to local, state, and national resources. Data collection includes computer-assisted baseline (in-person) and blinded quarterly (telephone) interviews with participants, collection of SSA administrative and site-level program data, site visits (including fidelity assessments), qualitative interviews with site administrators and service providers, focus groups with study participants, and person-centered ethnographic interviews with participants and nonparticipants. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03682263
Study type Interventional
Source Westat
Contact
Status Completed
Phase N/A
Start date December 2, 2017
Completion date March 31, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04254562 - Helping Youth on the Path to Employment N/A
Completed NCT03222596 - The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals N/A
Recruiting NCT06067373 - Impact and Burden of Postponing Elective Surgeries
Active, not recruiting NCT04463784 - Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV Infection N/A